New hope for rare scalp disease: biologics aim to stop painful flares and hair loss
NCT ID NCT07268534
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests biologic drugs for folliculitis decalvans, a rare scalp disease that causes painful pustules and permanent hair loss. Current antibiotics only work about half the time and the condition often returns. The trial will enroll 120 adults who have already tried at least two antibiotic treatments, and will measure if biologics can reduce disease severity over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULITIS DECALVANS (FD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.